Neuberger Berman Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234M Buy
646,798
+60,827
+10% +$20.8M 0.16% 130
2026
Q1
$206M Buy
585,971
+123,118
+27% +$43.9M 0.16% 139
2025
Q4
$152M Buy
462,853
+318,822
+221% +$101M 0.11% 211
2025
Q3
$40.6M Sell
144,031
-3,315
-2% -$961K 0.03% 510
2025
Q2
$41.1M Buy
147,346
+21,172
+17% +$6M 0.03% 485
2025
Q1
$39.3M Sell
126,174
-12,327
-9% -$3.64M 0.03% 482
2024
Q4
$36.1M Sell
138,501
-488,473
-78% -$145M 0.03% 524
2024
Q3
$202M Buy
626,974
+427,806
+215% +$140M 0.16% 166
2024
Q2
$62.3M Sell
199,168
-202,461
-50% -$59.5M 0.05% 375
2024
Q1
$114M Sell
401,629
-267,286
-40% -$78.2M 0.09% 260
2023
Q4
$193M Buy
668,915
+535,356
+401% +$146M 0.17% 164
2023
Q3
$35.9M Sell
133,559
-386,698
-74% -$96.5M 0.03% 470
2023
Q2
$116M Sell
520,257
-5,641
-1% -$1.31M 0.1% 243
2023
Q1
$127M Buy
525,898
+399,074
+315% +$98M 0.12% 230
2022
Q4
$33.3M Sell
126,824
-5,678
-4% -$1.52M 0.03% 501
2022
Q3
$29.9M Buy
132,502
+25,506
+24% +$6.18M 0.03% 524
2022
Q2
$26.1M Buy
106,996
+6,274
+6% +$1.54M 0.03% 567
2022
Q1
$24.4M Buy
100,722
+3,633
+4% +$835K 0.02% 627
2021
Q4
$20.6M Sell
97,089
-32,166
-25% -$6.79M 0.02% 682
2021
Q3
$27M Sell
129,255
-19,742
-13% -$4.54M 0.02% 604
2021
Q2
$35.7M Buy
148,997
+6,748
+5% +$1.66M 0.03% 556
2021
Q1
$34.9M Sell
142,249
-8,084
-5% -$1.93M 0.03% 538
2020
Q4
$34.4M Sell
150,333
-14,409
-9% -$3.32M 0.04% 506
2020
Q3
$41.8M Sell
164,742
-2,404
-1% -$596K 0.05% 401
2020
Q2
$39.4M Sell
167,146
-9,972
-6% -$2.28M 0.05% 407
2020
Q1
$35.9M Sell
177,118
-6,364
-3% -$1.39M 0.05% 382
2019
Q4
$44.2M Sell
183,482
-5,881
-3% -$1.3M 0.05% 420
2019
Q3
$36.6M Buy
189,363
+1,788
+1% +$343K 0.04% 445
2019
Q2
$34.6M Sell
187,575
-7,317
-4% -$1.31M 0.04% 470
2019
Q1
$37M Buy
194,892
+19,076
+11% +$3.64M 0.05% 448
2018
Q4
$34.2M Buy
175,816
+21,033
+14% +$4.1M 0.05% 436
2018
Q3
$32.1M Buy
154,783
+5,836
+4% +$1.15M 0.04% 511
2018
Q2
$27.6M Buy
148,947
+1,025
+0.7% +$181K 0.03% 553
2018
Q1
$25.3M Sell
147,922
-35,097
-19% -$6.44M 0.03% 581
2017
Q4
$32M Sell
183,019
-16,867
-8% -$2.99M 0.04% 524
2017
Q3
$37.3M Buy
199,886
+3,752
+2% +$665K 0.05% 460
2017
Q2
$33.8M Sell
196,134
-3,679
-2% -$598K 0.04% 478
2017
Q1
$32.8M Sell
199,813
-1,301
-0.6% -$216K 0.04% 483
2016
Q4
$29.4M Sell
201,114
-18,237
-8% -$2.74M 0.04% 491
2016
Q3
$36.6M Buy
219,351
+13,504
+7% +$2.28M 0.05% 451
2016
Q2
$31.3M Sell
205,847
-800
-0.4% -$124K 0.04% 489
2016
Q1
$31M Sell
206,647
-35,382
-15% -$5.26M 0.04% 471
2015
Q4
$39.3M Sell
242,029
-66,246
-21% -$10.4M 0.05% 434
2015
Q3
$42.6M Sell
308,275
-9,909
-3% -$1.56M 0.05% 415
2015
Q2
$48.8M Sell
318,184
-4,887
-2% -$783K 0.05% 424
2015
Q1
$51.6M Sell
323,071
-315
-0.1% -$49.6K 0.06% 416
2014
Q4
$51.5M Sell
323,386
-11,381
-3% -$1.77M 0.05% 418
2014
Q3
$47M Sell
334,767
-12,966
-4% -$1.69M 0.05% 444
2014
Q2
$41.2M Buy
347,733
+3,306
+1% +$383K 0.04% 476
2014
Q1
$42.5M Sell
344,427
-8,997
-3% -$1.09M 0.04% 452
2013
Q4
$40.3M Sell
353,424
-59,128
-14% -$6.73M 0.04% 463
2013
Q3
$46.2M Sell
412,552
-21,479
-5% -$2.33M 0.05% 425
2013
Q2
$42.8M Buy
+434,031
New +$45M 0.05% 422

Other funds holding AMGN

Neuberger Berman Group's AMGN Position: Q2 2026 in Review

Neuberger Berman Group increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $20.8M and bringing the position to 646,798 shares worth $234M. The position accounts for 0.16% of the portfolio, ranked #130.

Neuberger Berman Group first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Neuberger Berman Group held 646,798 shares of Amgen worth $234M as of Q2 2026.
  • Neuberger Berman Group bought 60,827 Amgen shares in Q2 2026, an estimated $20.8M.
  • Amgen made up 0.16% of Neuberger Berman Group's portfolio in Q2 2026, its #130 holding.
  • Neuberger Berman Group first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.